Doncaster and Bassetlaw Teaching Hospitals (DBTH) is encouraging those aged 65 and over to get their shingles and pneumococcal vaccines when offered, echoing the ongoing campaign by the NHS and ...

In addition to helping guide future vaccine designs, the hu1B7 and hu11E6 antibodies themselves hold promise as therapeutic medicines for infected and high-risk infants. Previous work by Maynard ...

Babies treated with antibiotics in the first few weeks of their life are likely to show weaker immune responses to essential ...

In addition to helping guide future vaccine designs, the hu1B7 and hu11E6 antibodies themselves hold promise as therapeutic medicines for infected and high-risk infants. Previous work by Maynard ...

No serious adverse events were considered to be related to the study vaccines. Post-dose 3, the VAX-24 Mid dose met target precedent Phase 2 non-inferiority (NI) criteria on relative ...

"IgG4 is primarily involved in regulatory functions, and is associated with immune tolerance and chronic antigen exposure," while IgG2 targets "polysaccharide ... the antibody class switch, which was ...

Merck, known as MSD outside of the United States and Canada, announced that the European Commission (EC) has approved Capvaxive (Pneumococcal 21-valent Conjugate Vaccine) for active immunization for ...

Merck & Co – known as MSD outside the US and Canada – has announced that its adult-specific 21-valent pneumococcal conjugate vaccine has been approved by the European Commission (EC). The vaccine, ...

This study evaluated the effects of an extended dose interval on development of antibody and cell-mediated responses following the primary dose series and a subsequent booster dose. Methods: Blood ...

including those in the capsular polysaccharide synthesis locus. Our findings show that the serotype and lineage, and possibly a combination of genomic loci, influence intrinsic pneumococcal growth ...

Participants were randomized to receive a single dose of either one of three lots of CAPVAXIVE or PPSV23 (pneumococcal 23-valent polysaccharide vaccine). Results from the study include ...